Position history for DODGE & COX's holdings in REGENERON PHARMACEUTICALS
DODGE & COX holds 4.6M shares of REGN (REGENERON PHARMACEUTICALS), worth $3.5B as of 2025-Q4. The position was increased (++1.0% shares). REGN represents 1.9% of DODGE & COX's portfolio.
Current Value
$3.5B
Current Shares
4.6M
Total Value Change
+$1.1B
Total Shares Change
+2.3M
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 4.6M |
+1.0% |
| $3.5B |
| 1.9% |
| $773.94 |
51 |
| 2025-Q3 | Increased | 4.6M | +18.9% | $2.6B | 1.4% | $560.05 | 59 |
| 2025-Q2 | Increased | 3.8M | +64.6% | $2B | 1.1% | $519.56 | 73 |
| 2025-Q1 | Increased | 2.3M | +0.1% | $1.5B | 0.8% | $634.66 | 45 |
| 2024-Q4 | Increased | 2.3M | +0.4% | $1.7B | 1.0% | $698.71 | 45 |
| 2024-Q3 | Decreased | 2.3M | -0.2% | $2.4B | 1.4% | $1,036.94 | 0 |
| 2024-Q2 | Decreased | 2.3M | -1.9% | $2.4B | 1.5% | $1,045.23 | 0 |